The Founder of GenScan AI, Ms Mary-Brenda Akoda has referred to as for elevated funding and institutional help to facilitate adoption of improvements.
Akoda, an Artificial Intelligence (AI) analysis scientist, made the decision throughout a information briefing on Sunday in Lagos.
She received the 2026 Nigeria Prize for Science and Innovation, 100,000 {dollars} prize cash sponsored by Nigeria Liquefied Natural Gas Ltd. (NLNG).
The scientist expressed concern that Nigerian sufferers may miss out on the advantages of homegrown medical expertise, if funding and institutional help had been inadequate to facilitate its adoption regionally.
She mentioned that entry to worldwide funding and collaboration with healthcare establishments was important to finishing medical validation and securing regulatory approval for GenMRI, her new innovation.
Akoda mentioned that the brand new invention was able to lowering Magnetic Resonance Imaging (MRI) scan time by as much as 90 per cent.
She mentioned that this might assist to speed up the medical adoption of her AI-powered medical imaging expertise in Nigeria.
Akoda mentioned that her speedy problem was transferring the expertise from profitable analysis validation to sensible deployment in hospitals, a course of requiring substantial funding in medical trials and regulatory compliance.
She recognized worldwide funding establishments, together with the Gates Foundation, Development Innovation Ventures Fund and Global Innovation Fund, as potential companions whose help may assist speed up the method.
“We find ourselves constrained by having to first deploy elsewhere and then have our own home country, Nigeria, as an afterthought.
“There is the need for partners willing to support clinical adoption in Nigeria,” Akoda mentioned.
She disclosed that the Ministry of Education had directed that medical pilots be facilitated, whereas discussions had been ongoing with related healthcare stakeholders to advance the method.
The researcher mentioned that she was working with medical companions in Nigeria, the United Kingdom, the United States and Kenya to broaden GenScan’s validation throughout totally different physique areas and medical settings.
According to her, the innovation has been validated utilizing greater than 8,800 MRI photos and achieved as much as 99.7 per cent similarity to standard MRI photos.
She revealed that an early blinded evaluation by a marketing consultant radiologist at Buckinghamshire Healthcare NHS Trust within the United Kingdom additionally discovered the photographs diagnostically equal to standard scans in all instances assessed.
Akoda, nevertheless, emphasised that additional medical research and regulatory approvals had been obligatory earlier than the expertise might be deployed for routine medical use.
She mentioned that GenMRI was designed to assist hospitals look at extra sufferers utilizing present MRI scanners, lowering ready occasions and the necessity for pricey investments in extra tools.
According to her, high-quality MRI scanners can price between $1.5 million and $3.5 million or extra.
She mentioned that the price made it tough for healthcare amenities to increase their diagnostic capability by means of tools purchases.
Beyond the expertise’s technical capabilities, Akoda mentioned that her broader ambition was to bridge the hole between medical analysis and the individuals who want its advantages.
“I don’t believe that innovations should remain on paper. The whole idea of a healthcare innovation is that it eventually transforms the lives of the people who need it most,” she mentioned.
Akoda mentioned that her imaginative and prescient for GenScan AI was to make sure that nobody suffered or died due to delayed prognosis.
She attributed her motivation to a private expertise involving the demise of an aged beloved one following a stroke, which uncovered the possibly devastating penalties of delays in medical prognosis.
Akoda mentioned that the expertise prompted her to analyze how AI may assist healthcare professionals overcome systemic challenges and enhance diagnostic effectivity.
The researcher additionally referred to as for stronger collaboration between AI scientists and clinicians, saying that medical applied sciences have to be developed round precise healthcare wants reasonably than in isolation.
Akoda mentioned that her goal was to deploy GenMRI within the second half of 2027, topic to funding, medical validation and regulatory approval.
She urged authorities establishments, healthcare suppliers and worldwide growth companions to help efforts to carry the expertise to Nigerian hospitals, noting that its final worth would depend upon its accessibility to sufferers. (NAN)(NAN)
Edited by Florence Onuegbu
